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ABSTRACT
BACKGROUND
Different clinical and epidemiological studies using dual-energy X-ray ab-
sorptiometry have shown an increased prevalence of low bone mineral density 
in patients with inflammatory bowel diseases. The aim of this study was to 
assess the correlation between bone density and the disease activity in patients 
with ulcerative colitis.
METHODS 
In this cross-sectional study, 52 patients with ulcerative colitis (duration of 
the disease less than 5 years) were invited to our research center, Golestan prov-
ince, northeast of Iran, during February 2012 up to August 2012. A demographic 
checklist and Simple Clinical Colitis Activity Index was completed for each pa-
tients and 5 cc of blood sample was taken after obtaining the informed consent. 
We used colorimetry method for measuring serum calcium, UV method for se-
rum phosphorus and ELISA for serum vitamin D. Dual-energy X-ray absorp-
tiometry was done to evaluate the bone density. Data analysis was done using 
SPSS software version 16. Normality of data was assessed using Kolmogorov–
Smirnov test. T and ANOVA tests were used if data had normal distribution. 
Mann-Whitney U or Kruskal-Wallis tests were used for the remaining data. Cor-
relation between qualitative variables was evaluated by Chi-square test.
RESULTS 
The mean (±SD) age and disease activity of the patients were 37.72 (±12.18) 
years and 4.78 (±1.98), respectively. There were no correlation between dis-
ease activity and mean age. Low bone density was seen in 30.8%, 11.5%, and 
15.4% in spine, femur neck, and hip, respectively. There was no relationship 
between Z-score of total hip, spine, and femur neck with disease activity, age, 
and duration of disease (p>0.05). 
CONCLUSION
Our results showed an acceptable rate of low bone density in patients with 
ulcerative colitis without any correlation with the disease activity index.
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INTRODUCTION    
Inflammatory bowel disease (IBD) is an immune 
based disorder that is more prevalent in Caucasians. 
Its incidence is increasing in these populations,1 
which could have several complications. Osteoporo-
sis (low bone density) is one of the most common 
and important consequences of inflammation in the 
bowel mucosa.2
Different clinical and epidemiological studies us-
ing dual-energy X-ray absorptiometry(DXA) have 
shown an increased prevalence of low bone mineral 
density (BMD) in patients with IBD.3 Risk of patho-
logic fractures among patients with IBD is reported 
to be higher than general population.4
Some investigators reported that low BMD was 
more common in Crohn’s disease (CD) than ulcer-
ative colitis (UC); although other studies indicated 
that both diseases had the same degrees of bone 
loss.5 Using the World Health Organization (WHO) 
criteria, studies have shown a prevalence of 40-50% 
for osteopenia and 10-25% for osteoporosis in pa-
tients with IBD, which are together defined as low 
bone density.6
Several factors can play role in the pathogenesis 
of low BMD (osteoporosis) in IBD such as cortico-
steroid therapy, malnutrition, small bowel resection, 
vitamin D (25-hydroxyvitamin D [25- OHD]) and 
calcium deficiency, hypogonadism, disease activity 
and duration, sex hormones deficiency, smoking, 
proinflammatory cytokines, and genetic.2-4 Among 
these factors, it has been proven that age and cortico-
steroid use have a more important role in lower bone 
density.7 So, normal bone modeling and remodeling 
can be affected by IBDs by various factors, resulting 
in decreased bone formation and/or increased bone 
resorption.6 Moreover, vitamin D deficiency may 
induce rising in PTH levels and 1, 25(OH)2 D via 
causing hypocalcaemia. This form of vitamin D [1, 
25(OH)2D] activates osteoclastic function and leads 
to mobilization of skeletal calcium stores. Also vi-
tamin D deficiency can affect calcium metabolism, 
matrix ossification, the rate of bone turnover, and 
bone mineral density.6,8 In patients with IBD, cal-
cium intake does not show predictor effect on bone 
mineral density while decreased intake causes lower 
bone mineral density.8
Non-invasive method of DXA made it is easy to 
measure BMD. There are two different score for 
showing BMD results as the number of standard de-
viations (SD) above or below the mean for a young 
adult population (T-score) or an age-matched popu-
lation (Z-score).7
There are controversies regarding the magnitude 
of low bone density in patients with IBDs and the 
suitable therapeutic approach.7 This study was de-
signed in a population of ulcerative colitis cases in 
Northeast of Iran to measure the bone density and 
evaluate the relationship of the colitis activity and 
the bone density in these patients.
MATERIALS AND METHODS
This cross-sectional study was conducted in 
2012 in Golestan province (northeast of Iran). All 
patients with a definite diagnosis of ulcerative coli-
tis (based on colonoscopy and histopathological 
confirmation) during the previous 5 years were en-
rolled. The protocol of this project was confirmed 
in the local Ethics Committee of Golestan Univer-
sity of Medical Sciences and informed consent was 
taken from all the patients. 
Inclusion criteria were: Duration of diagnosis not 
more than 5 years (to decrease the probability of the 
disease complications), no history of smoking, not 
being in acute phase of the disease, and no need to 
hospital admission at the time of study.
Those patients who had a history of corticoste-
roids consumption in the previous six months were 
excluded from the study. Fifty two patients who met 
the inclusion criteria were referred to Golestan Re-
search Center of Gastroenterology and Hepatology 
(GRCGH). A checklist including demographic in-
formation (age and sex) and data about the duration 
of disease, any complication related to the intestinal 
disease and history of treatment was completed for 
each patient. Simple clinical colitis activity index 
(SCCAI) was used to evaluate the disease activity. 
This index, which was defined firstly by Walmsley 
in 1998, consisted of scores for five clinical criteria 
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and showed a highly significant correlation with ex-
isting more complex scoring systems and therefore 
could be useful in the initial assessment of patients 
with ulcerative colitis.9
SCCAI is a 5-item questionnaire that assesses 
the severity of bowel disease using clinical symp-
toms including number of defecations in a day, 
during the night, emergency feeling for defecation, 
seeing blood in the stool, general feeling of well-
being, and extra-intestinal manifestations. Persian 
version of this questionnaire is not validated in our 
country. So for using in this study we translated it to 
Persian and culturally adapted following the stan-
dard forward- backward translation method. Then it 
was explained for 10 patients with ulcerative colitis 
to see if there is any problem in understanding the 
questions as a pilot study. Results showed that all 
patients fulfilled the questionnaire completely. So, 
during the study a medical doctor performed the in-
terview trying to help the patients understand the 
items well.
The patients were referred to 5th Azar hospital 
(the academic hospital affiliated to the Univer-
sity) for measuring BMD by DXA (Lexxos-DMS, 
France). Z-Score less than -2 was considered as low 
bone density based on the latest recommendations 
of International Society for Clinical Densitometry 
(ISCD).10
Fasting blood sample was taken to detect serum 
levels of calcium (Ca), phosphorous (P), and vita-
min D3. Our measuring methods were colorimetry 
for Ca (Pars Azmoon, Iran), UV method for P (Pars 
Azmoon, Iran), and ELISA for vitamin D (Euroim-
mune, Germany).
Data analysis was done using SPSS software ver-
sion 16. Normality of data was assessed using Kol-
mogorov–Smirnov test. T and ANOVA tests were 
used if the data had normal distribution. Mann-
Whitney U or Kruskal-Wallis tests were used for 
the remaining data. Correlation between qualitative 
variables was evaluated by Chi-square test.
RESULTS 
Of the patients, 61.5% were women and the re-
maining were men (38.5%). Mean (±SD) patients’ 
age was 37.72(±12.18) years. There was no sig-
nificant difference in age between men and women 
(p=0.40).
Simple clinical colitis activity index varied from 
3 to 13. There was no significant difference in dis-
ease activity index between men (4.52±2.31) and 
women (4.47 ±1.44) (p=0.29).
No significant correlation was seen between ac-
tivity index or disease duration and BMD (p>0.05). 
The result of bone densitometry showed no low 
mineral density in total hip and femoral neck of the 
patients but 36.6% of them had low bone density in 
lumbar vertebra (table 1).
There was no significant difference between 
BMD of total hip (p=0.94), femoral neck (p=0.13), 
and lumbar vertebra (p=0.38) in men and women. 
Also no correlation was found between mean age of 
patients with low mineral density and normal group 
(p>0.05,table 2).
As shown in table 3, serum levels of calcium, 
phosphorus, and vitamin D were normal in our pa-
tients (table 3).
DISCUSSION
Results of this study on patients with ulcerative 
colitis showed a prevalence of about 30.8%, 11.5%, 
and 15.4% low bone density (Z-score<-2) in spine, 
femur neck, and hip area. No correlation between 
disease activity index and bone density was found. 
And none of our patients had abnormal amounts of 
calcium, phosphorus, and vitamin D (as shown in 
table 3). We had no control group in our research 
(one of our limitations) and some comparisons 
could not be done exactly.
Clinical data from different studies showed a 
variety of low bone density prevalence in various 
populations. Although there has been a discordance 
between the results depending on using Z-score or 
T-score,2 either of them could be used in evaluation 
of bone density of patients. In this study we used 
Z-score based on the newest definition by ISCD.10
Khadgawat and colleagues had shown that spine 
and hip BMD in patients with IBD in India was sig-
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nificantly lower than the control group. No asso-
ciation was found between BMD and age, disease 
duration, and cumulative dose of corticosteroids. In 
this study, two-thirds of the patients had low BMD 
(according to WHO definition of osteoporosis and 
osteopenia) and daily calcium intake was inade-
quate in most patients.11 Although the prevalence of 
low BMD was higher in Indian patients, the result 
of this study was similar to ours in regard to the low 
correlation between age and the disease duration 
with BMD. Although daily calcium intake of pa-
tients was not examined in our study, it seems there 
was no problem in terms of serum calcium of our 
patients. Since World Health Organization (WHO) 
has released a different definition for low bone den-
sity (bone densitometry as a T score -1 to -2.5),12 
there might be some differences between the results 
using T-score or Z-score in the analyses.
In the study by Tsironi and co-workers on 122 
patients with IBD, age (older than 55 years) was 
identified as a risk factor for low femoral neck T-
score. But the index of disease activity, disease 
duration, and sex did not have predictive value for 
bone density.7 In our study, there was no relation-
ship between disease duration and sex of patients 
with low bone density. In contrast to the mentioned 
study, no relationship was found between age and 
femoral neck T-score. It should be considered in 
mind that our patients were mostly younger than 50 
years old (except for nine of them). So, there could 
be some correlation with age if there was a higher 
proportion of older patients in the study. This might 
be an issue of interest for further studies.
Similarly, there have been reported a much high-
er prevalence of low bone density in different stud-
ies from all over the world. In Austria, Kirchgatter-
er and colleagues reported low bone density in 27 
patients with ulcerative colitis (71%), osteopenia in 
20, and osteoporosis in 7 patients. Their findings 
can be due to the different definition used in their 
study.13 In the present study, we just used the term 
“low bone density” which includes both osteopo-
rosis and osteopenia, so about 37% of our patients 
had low bone density in lumbar vertebra that is so 
much better results compared with the above men-
tioned report. 
Another example is the study by Ardizzo and 
colleagues in Italy on 51 patients with Crohn’s dis-
ease and 40 patients with ulcerative colitis. They 
showed a similar T score in both groups, and only 
8% of the patients with Crohn’s disease, and 15% 
of the patients with ulcerative colitis had normal 
bone density. In the Regression models, the femur T 
score was significantly associated with duration of 
Crohn’s disease. In patients with ulcerative colitis, 
spine T score was inversely associated with age and 
significantly correlated with sex of the individual 
(male). Femur T score was significantly associated 
with sex (men were more negative) and inversely 
related to the cumulative dose of prednisone.14 We 
did not find a significant relationship between age, 
sex, and T-score. None of our patients were taking 
long-term corticosteroids. Also, we had no patient 
with Crohn’s disease, and our analysis was mainly 
based on Z-score.
Some similar studies have been done in Iranian 
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Table 1: Bone density classification of hip, femoral neck, and 
lumbar vertebra in patients with ulcerative colitis
Region of Interest (ROI)
Low Bone Density 
N (%)
Normal 
N (%)
Total hip(Z-Score) 8 (15.4) 44 (84.6)
Femoral neck (Z-Score) 6 (11.5) 46 (88.5)
Lumbar vertebra (Z-Score) 19 (36.6) 33 (63.5)
Table 2: Mean (±SD) age of patients with ulcerative colitis and bone 
mineral density
Region of Interest 
(ROI)
Mean (± SD) age
p-value
normal Low bone density
Total hip(Z-Score) 38.82(±12.77) 32.37(±7.08) 0.059
Femoral neck (Z-Score) 38.71(±12.3) 29.4(±7.76) 0.134
  
Table 3: Mean (±SD) serum level of calcium, phosphorus, 
and vitamin D in patients with ulcerative colitis
Variable Mean (±SD) Normal Range
Phosphorus (mg/dL) 8.89 (0.48) 2.5-4.3
Vitamin D(ng/mL) 3.97 (4.24) 2.5-32
Calcium(mg/dL) 72.04 (39.44) 7.8-10.2
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patients with IBD. In Zali et al. study on 126 pa-
tients with ulcerative colitis and 39 patients with 
Crohn’s disease in Tehran, 53 patients (1.32%) 
had decreased bone density of the lumbar spine 
or femoral neck. The density of the femoral neck 
was significantly reduced in patients with Crohn’s 
disease. There were no differences between men 
and women in terms of bone mass. Most of the 
patients with Crohn’s had hypocalcemia. Regres-
sion analysis showed that lumbar spine T-score was 
predictable with age, body mass index, and use of 
corticosteroids, whereas in the femoral neck, these 
factors were age, body mass index, smoking, and 
corticosteroid intake.15 We did not enroll patients 
with Crohn’s into the study, due to the low number 
of such patients in our region. Furthermore, in our 
study number of those with low bone density at the 
lumbar spine was lower than the mentioned study. 
The intake of calcium could be responsible for it, 
which was not measured in our study and it should 
be considered in next studies.
Shiraziand colleagues in a study on 200 patients 
with IBD in Tabriz reported that 74.4% of their pa-
tients had low bone density at the lumbar spine or 
femoral neck. Half of the patients were osteopenic 
and 24.1% were osteoporotic. The mean serum cal-
cium was in the normal range. In Patients with ul-
cerative colitis inverse association between T score, 
alkaline phosphatase, and 25-hydroxyvitamin D 
was observed.16 This report was similar to ours in 
regard to the normal range of calcium in patients 
with IBD, but there were more patients with low 
bone density than ours. There could be a difference 
because of the different duration of disease in their 
study.
Recently, a case-control study in Iran was per-
formed by Mikaeli and co-workers, which showed 
no significant difference between patients with 
IBDs and controls in BMD of lumbar spine, femo-
ral neck, and total hip or between men and women. 
They concluded that among different assumed risk 
factors, just aging and long-term use of corticoste-
roids really matter in decreased BMD in patients 
with ulcerative colitis.2 In the present study, we did 
not include patients with long term usage of corti-
costeroids and also the mean age of our population 
was young. So these two important factors could 
not be implied in low bone densitometry in our 
study.
Our patients with ulcerative colitis had an ac-
ceptable bone density compared with other stud-
ies and low calcium and vitamin D level were not 
observed. Lack of dietary data and control group 
were our limitations. Daily calcium and vitamin D 
intake in patients with IBD could be a topic for fu-
ture studies. 
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